BACKGROUND: Although mouse allergen exposure is common in inner-city homes, little is known about the relationships between exposure and humoral immune responses to mouse allergen in this population. OBJECTIVE: To examine relationships between mouse allergen exposure and allergen-specific IgE and IgG responses in inner-city children with asthma. METHODS: Inner-city children with asthma underwent skin testing and venipuncture for determination of mouse allergen-specific IgE and IgG levels. Settled dust samples were collected from their homes for allergen analysis. RESULTS: The study population (n = 112) was predominantly African American (92%) with a mean age of 4.4 years. The prevalence rate of mouse sensitization was 25% and did not consistently increase with increasing Mus m 1 levels. Instead, the prevalence rate was lowest among those exposed to <2 microg/g, increased among those exposed to 2-7.9 microg/g and 8-29.9 microg/g, and then decreased among participants exposed to >29.9 microg/g (14%, 20%, 40%, and 28%, respectively). Similarly, the prevalence rates of mouse allergen-specific IgG and IgG(4) did not increase across increasing exposure categories. Mouse allergen-specific IgG and IgG(4) were strongly associated with IgE sensitization (odds ratios [95% CI], 82.8 [20.5-334.4] and 50.4 [14.0-181.7], respectively). CONCLUSION: High-level exposure to mouse allergen in children may be associated with attenuated humoral responses of all isotypes rather than selective attenuation of IgE. CLINICAL IMPLICATIONS: Protection against allergic sensitization by high-dose allergen exposure may not be mediated by preferential production of IgG over IgE.
BACKGROUND: Although mouse allergen exposure is common in inner-city homes, little is known about the relationships between exposure and humoral immune responses to mouse allergen in this population. OBJECTIVE: To examine relationships between mouse allergen exposure and allergen-specific IgE and IgG responses in inner-city children with asthma. METHODS: Inner-city children with asthma underwent skin testing and venipuncture for determination of mouse allergen-specific IgE and IgG levels. Settled dust samples were collected from their homes for allergen analysis. RESULTS: The study population (n = 112) was predominantly African American (92%) with a mean age of 4.4 years. The prevalence rate of mouse sensitization was 25% and did not consistently increase with increasing Mus m 1 levels. Instead, the prevalence rate was lowest among those exposed to <2 microg/g, increased among those exposed to 2-7.9 microg/g and 8-29.9 microg/g, and then decreased among participants exposed to >29.9 microg/g (14%, 20%, 40%, and 28%, respectively). Similarly, the prevalence rates of mouse allergen-specific IgG and IgG(4) did not increase across increasing exposure categories. Mouse allergen-specific IgG and IgG(4) were strongly associated with IgE sensitization (odds ratios [95% CI], 82.8 [20.5-334.4] and 50.4 [14.0-181.7], respectively). CONCLUSION: High-level exposure to mouse allergen in children may be associated with attenuated humoral responses of all isotypes rather than selective attenuation of IgE. CLINICAL IMPLICATIONS: Protection against allergic sensitization by high-dose allergen exposure may not be mediated by preferential production of IgG over IgE.
Authors: Jean Curtin-Brosnan; Beverly Paigen; Karol A Hagberg; Stephen Langley; Elise A O'Neil; Mary Krevans; Peyton A Eggleston; Elizabeth C Matsui Journal: J Occup Environ Hyg Date: 2010-12 Impact factor: 2.155
Authors: E C Matsui; H A Sampson; H T Bahnson; R S Gruchalla; J A Pongracic; S J Teach; P J Gergen; G R Bloomberg; J F Chmiel; A H Liu; M Kattan; C A Sorkness; S F Steinbach; R E Story; C M Visness Journal: Allergy Date: 2010-11 Impact factor: 13.146
Authors: William J Sheehan; Pitud A Rangsithienchai; Robert A Wood; Don Rivard; Sasawan Chinratanapisit; Matthew S Perzanowski; Ginger L Chew; James M Seltzer; Elizabeth C Matsui; Wanda Phipatanakul Journal: J Allergy Clin Immunol Date: 2010-03 Impact factor: 10.793
Authors: Roger D Peng; Beverly Paigen; Peyton A Eggleston; Karol A Hagberg; Mary Krevans; Jean Curtin-Brosnan; Cristy Benson; Wayne G Shreffler; Elizabeth C Matsui Journal: J Allergy Clin Immunol Date: 2011-06-22 Impact factor: 10.793
Authors: Wanda Phipatanakul; Elizabeth Matsui; Jay Portnoy; P Brock Williams; Charles Barnes; Kevin Kennedy; David Bernstein; Joann Blessing-Moore; Linda Cox; David Khan; David Lang; Richard Nicklas; John Oppenheimer; Christopher Randolph; Diane Schuller; Sheldon Spector; Stephen A Tilles; Dana Wallace; James Sublett; Jonathan Bernstein; Carl Grimes; J David Miller; James Seltzer Journal: Ann Allergy Asthma Immunol Date: 2012-12 Impact factor: 6.347
Authors: Tammy S Jacobs; Erick Forno; John M Brehm; Edna Acosta-Pérez; Yueh-Ying Han; Joshua Blatter; Peter Thorne; Nervana Metwali; Angel Colón-Semidey; María Alvarez; Glorisa Canino; Juan C Celedón Journal: Ann Allergy Asthma Immunol Date: 2014-10-07 Impact factor: 6.347
Authors: Kathleen M Donohue; Umaima Al-alem; Matthew S Perzanowski; Ginger L Chew; Alina Johnson; Adnan Divjan; Elizabeth A Kelvin; Lori A Hoepner; Frederica P Perera; Rachel L Miller Journal: J Allergy Clin Immunol Date: 2008-11 Impact factor: 10.793